Nonclinical Biostatistics Working Group

Objectives    Activities   Steering Committee

 of the Nonclinical Biostatistics Working Group (NCBWG) 

  • Promote the theory and applications of nonclinical biostatistical disciplines through scholarly activities, including publication of journals in statistics and probability, scientific meetings, and other educational programs
  • Broaden applications of nonclinical biostatistical techniques in all areas of society, including industry and government
  • to promote better understanding and interest by the general public in nonclinical biostatistical methodology and related applications
  • Promote better communication through the development of standards and common terminology
  • Foster cooperative efforts among educational, research, industrial, and governmental personnel in non-clinical statistical activities

Click here for a history of the NCBWG.




NCB Conference

Paul Faya (Eli Lilly)

John Kolassa (Rutgers)

Student Outreach

Jyh-Ming Shoung (Janssen)

Wei Zhao (Fate Therapeutics)

Stan Altan Best Nonclinical Paper Award

Angel Lu (PharmaLex)

Communications & Public Outreach

Kristi Griffiths (Eli Lilly)

Nonclinical Statistics Scholarship

John Kolassa (Rutgers)

Scientific Workstreams:

Bayesian CMC

  Christopher Thompson (AZ)

  Ji Young Kim (Merck)

Bayesian Preclincal

  Yushi Liu (Eli Lilly)

  Tony Pourmohamad (Genentech)

Nonnormal distributions

Jose Ramirez (Kite)

Comparability (CMC)

Aili Cheng (Pfizer)

Steering Committee

Eve Pickering (chair), Pfizer

Steven Novick (past chair), Takeda

Mariusz Lubormirski, Amgen

Chi-Hse Teng, Novartis

Katja Remlinger, GSK

Xin Huang, AbbVie

Paul Faya, Eli Lilly

For information about the NCBWG, please contact the Chair: Eve Pickering